These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1060 related items for PubMed ID: 17154048

  • 1. [Protective immunity against Mycobacterium tuberculosis].
    Kawamura I.
    Kekkaku; 2006 Nov; 81(11):687-91. PubMed ID: 17154048
    [Abstract] [Full Text] [Related]

  • 2. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M, Shirakawa T.
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [Abstract] [Full Text] [Related]

  • 3. Induction of in vitro human macrophage anti-Mycobacterium tuberculosis activity: requirement for IFN-gamma and primed lymphocytes.
    Bonecini-Almeida MG, Chitale S, Boutsikakis I, Geng J, Doo H, He S, Ho JL.
    J Immunol; 1998 May 01; 160(9):4490-9. PubMed ID: 9574555
    [Abstract] [Full Text] [Related]

  • 4. Apoptosis facilitates antigen presentation to T lymphocytes through MHC-I and CD1 in tuberculosis.
    Schaible UE, Winau F, Sieling PA, Fischer K, Collins HL, Hagens K, Modlin RL, Brinkmann V, Kaufmann SH.
    Nat Med; 2003 Aug 01; 9(8):1039-46. PubMed ID: 12872166
    [Abstract] [Full Text] [Related]

  • 5. The Ag85B protein of Mycobacterium tuberculosis may turn a protective immune response induced by Ag85B-DNA vaccine into a potent but non-protective Th1 immune response in mice.
    Palma C, Iona E, Giannoni F, Pardini M, Brunori L, Orefici G, Fattorini L, Cassone A.
    Cell Microbiol; 2007 Jun 01; 9(6):1455-65. PubMed ID: 17250590
    [Abstract] [Full Text] [Related]

  • 6. The role of toll-like receptor 2 in survival strategies of Mycobacterium tuberculosis in macrophage phagosomes.
    Yoshida A, Inagawa H, Kohchi C, Nishizawa T, Soma G.
    Anticancer Res; 2009 Mar 01; 29(3):907-10. PubMed ID: 19414326
    [Abstract] [Full Text] [Related]

  • 7. Apoptosis paves the detour path for CD8 T cell activation against intracellular bacteria.
    Winau F, Kaufmann SH, Schaible UE.
    Cell Microbiol; 2004 Jul 01; 6(7):599-607. PubMed ID: 15186397
    [Abstract] [Full Text] [Related]

  • 8. Lymphocyte-dependent inhibition of growth of virulent Mycobacterium tuberculosis H37Rv within human monocytes: requirement for CD4+ T cells in purified protein derivative-positive, but not in purified protein derivative-negative subjects.
    Silver RF, Li Q, Boom WH, Ellner JJ.
    J Immunol; 1998 Mar 01; 160(5):2408-17. PubMed ID: 9498784
    [Abstract] [Full Text] [Related]

  • 9. [Evolution of IGRA researches].
    Ariga H, Harada N.
    Kekkaku; 2008 Sep 01; 83(9):641-52. PubMed ID: 18979999
    [Abstract] [Full Text] [Related]

  • 10. MyDths and un-TOLLed truths: sensor, instructive and effector immunity to tuberculosis.
    Reiling N, Ehlers S, Hölscher C.
    Immunol Lett; 2008 Feb 15; 116(1):15-23. PubMed ID: 18191460
    [Abstract] [Full Text] [Related]

  • 11. Immunology of tuberculosis.
    Raja A.
    Indian J Med Res; 2004 Oct 15; 120(4):213-32. PubMed ID: 15520479
    [Abstract] [Full Text] [Related]

  • 12. Human alveolar T lymphocyte responses to Mycobacterium tuberculosis antigens: role for CD4+ and CD8+ cytotoxic T cells and relative resistance of alveolar macrophages to lysis.
    Tan JS, Canaday DH, Boom WH, Balaji KN, Schwander SK, Rich EA.
    J Immunol; 1997 Jul 01; 159(1):290-7. PubMed ID: 9200465
    [Abstract] [Full Text] [Related]

  • 13. XCL1 (lymphotactin) chemokine produced by activated CD8 T cells during the chronic stage of infection with Mycobacterium tuberculosis negatively affects production of IFN-gamma by CD4 T cells and participates in granuloma stability.
    Ordway D, Higgins DM, Sanchez-Campillo J, Spencer JS, Henao-Tamayo M, Harton M, Orme IM, Gonzalez Juarrero M.
    J Leukoc Biol; 2007 Nov 01; 82(5):1221-9. PubMed ID: 17699612
    [Abstract] [Full Text] [Related]

  • 14. IL-10 down-regulates costimulatory molecules on Mycobacterium tuberculosis-pulsed macrophages and impairs the lytic activity of CD4 and CD8 CTL in tuberculosis patients.
    de la Barrera S, Aleman M, Musella R, Schierloh P, Pasquinelli V, Garcia V, Abbate E, Sasiain Mdel C.
    Clin Exp Immunol; 2004 Oct 01; 138(1):128-38. PubMed ID: 15373915
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Apoptosis of immune system cells in tuberculosis infection].
    Pichugin AV.
    Probl Tuberk Bolezn Legk; 2005 Oct 01; (12):3-7. PubMed ID: 16496753
    [Abstract] [Full Text] [Related]

  • 19. [Novel vaccines against M. tuberculosis].
    Okada M.
    Kekkaku; 2006 Dec 01; 81(12):745-51. PubMed ID: 17240920
    [Abstract] [Full Text] [Related]

  • 20. Recruitment of Mycobacterium tuberculosis specific CD4+ T cells to the site of infection for diagnosis of active tuberculosis.
    Nemeth J, Winkler HM, Zwick RH, Rumetshofer R, Schenk P, Burghuber OC, Graninger W, Ramharter M, Winkler S.
    J Intern Med; 2009 Jan 01; 265(1):163-8. PubMed ID: 18793244
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 53.